Please provide your email address to receive an email when new articles are posted on . Researchers assessed high-flow nasal therapy in two sequences. The changes in dyspnea and respiratory drive with ...
LAS VEGAS, NV—The diversion of blood flow through arterialization of the deep veins in the foot holds up well at 2 years as a therapy for “no-option” patients with chronic limb-threatening ischemia ...
Objective Knee osteoarthritis (KOA) is a leading cause of global disability and remains challenging to treat. Blood flow restriction (BFR) shows promising rehabilitation outcomes, but its lasting ...
Corresponding author Akshay Sharma, MBBS, MSc, St. Jude Department of Bone Marrow Transplantation and Cellular Therapy talks to St. Jude patient enrolled on the reported clinical trial, Corey Luellen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback